Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Bladder cancer 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
2 Bladder cancer 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
3 Bladder cancer 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
4 Bladder cancer 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
5 Bladder cancer 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
6 Bladder cancer 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
7 Calcium signaling pathway 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
8 Calcium signaling pathway 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
9 Calcium signaling pathway 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
10 Calcium signaling pathway 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
11 Calcium signaling pathway 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
12 Calcium signaling pathway 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
13 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
14 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
15 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
16 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
17 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
18 Central carbon metabolism in cancer 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
19 Endocytosis 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
20 Endocytosis 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
21 Endocytosis 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
22 Endocytosis 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
23 Endocytosis 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
24 Endocytosis 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
25 MAPK signaling pathway 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
26 MAPK signaling pathway 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
27 MAPK signaling pathway 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
28 MAPK signaling pathway 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
29 MAPK signaling pathway 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
30 MAPK signaling pathway 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
31 MicroRNAs in cancer 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
32 MicroRNAs in cancer 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
33 MicroRNAs in cancer 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
34 MicroRNAs in cancer 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
35 MicroRNAs in cancer 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
36 MicroRNAs in cancer 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
37 Pathways in cancer 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
38 Pathways in cancer 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
39 Pathways in cancer 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
40 Pathways in cancer 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
41 Pathways in cancer 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
42 Pathways in cancer 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
43 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
44 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
45 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
46 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
47 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
48 PI3K-Akt signaling pathway 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
49 Rap1 signaling pathway 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
50 Rap1 signaling pathway 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
51 Rap1 signaling pathway 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
52 Rap1 signaling pathway 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
53 Rap1 signaling pathway 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
54 Rap1 signaling pathway 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
55 Ras signaling pathway 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
56 Ras signaling pathway 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
57 Ras signaling pathway 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
58 Ras signaling pathway 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
59 Ras signaling pathway 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
60 Ras signaling pathway 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
61 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
62 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
63 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
64 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
65 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
66 Regulation of actin cytoskeleton 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬
67 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
68 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
69 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
70 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
71 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
72 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR3 💬 Recifercept 💬 Recifercept 1件: 276 💬